Angiotensin II type I receptor blocker, Losartan, inhibits fibrosis in liver by suppressing TGF-beta1 productionHisanobu Ogata, Kenzaburo Tani, Hideko Noguchi et al.|Integrative Molecular Medicine|2016Cited by 7
Present status of hepatitis medical care coordinators in regional core centers in JapanMasaru Enomoto, Masaaki Korenaga, Yoshihito Uchida et al.|Kanzo|2021Cited by 6
Present status of hepatitis medical care coordinators in regional core centers for liver disease management in Japan (second report)Hiroshi Isoda, Masaaki Korenaga, Masaru Enomoto et al.|Kanzo|2023Cited by 2